Schedule 13G ownership disclosure

Sagent Pharmaceuticals, Inc.

Security class unavailable · CUSIP: 786692103

Event date: 2016-08-29

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
0.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000904454-16-001429
Form type
SC 13G/A
Filer
Sagent Pharmaceuticals, Inc.
CIK
CIK 1369786
Filed
Sep 02, 2016
Reporting period
Aug 29, 2016
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub